Predictions
Frequentis AG
Start price
Target price
Perf. (%)
€25.10
19.09.21
19.09.21
€30.00
19.09.22
19.09.22
36.26%
07.01.22
07.01.22
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Revenue growth >5% per year expected
AT&S Austria Technologie & Systemtechnik AG
Start price
Target price
Perf. (%)
€35.60
19.09.21
19.09.21
€60.00
19.09.22
19.09.22
28.37%
16.06.22
16.06.22
Gaotu Techedu Inc. ADR
Start price
Target price
Perf. (%)
€2.07
19.09.21
19.09.21
-
19.09.22
19.09.22
21.26%
02.10.21
02.10.21
Risky Investment
MacroGenics Inc.
Start price
Target price
Perf. (%)
€16.79
19.09.21
19.09.21
-
19.09.22
19.09.22
-79.51%
20.09.22
20.09.22
Probably not worthwhile Investment
Abeona Therapeutics Inc.
Start price
Target price
Perf. (%)
€25.05
19.09.21
19.09.21
-
19.09.22
19.09.22
-85.23%
20.09.22
20.09.22
Growths faster than the competition
Risky Investment
Celyad SA ADR
Start price
Target price
Perf. (%)
€3.58
19.09.21
19.09.21
-
19.09.22
19.09.22
-53.35%
20.09.22
20.09.22
Probably not worthwhile Investment
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.20
18.09.21
18.09.21
€10.00
31.12.23
31.12.23
-79.42%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Spectrum Pharmaceuticals
Start price
Target price
Perf. (%)
€2.60
18.09.21
18.09.21
€5.00
31.12.23
31.12.23
-62.67%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€14.20
18.09.21
18.09.21
€40.00
31.12.23
31.12.23
61.97%
16.12.21
16.12.21
Could be very worthwhile Investment >20% year
Innate Pharma
Start price
Target price
Perf. (%)
€6.61
18.09.21
18.09.21
€3.00
18.09.22
18.09.22
-22.01%
02.10.21
02.10.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
micromobility.com Inc.
Start price
Target price
Perf. (%)
€693.90
18.09.21
18.09.21
€350.00
18.09.22
18.09.22
-22.18%
02.10.21
02.10.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Low dividend yield expected
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€5.20
18.09.21
18.09.21
€2.00
18.09.22
18.09.22
-22.69%
02.10.21
02.10.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
FM Mattsson Mora Group
Start price
Target price
Perf. (%)
€8.23
18.09.21
18.09.21
-
18.09.22
18.09.22
-17.00%
02.03.22
02.03.22
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€30.00
18.09.21
18.09.21
-
18.09.22
18.09.22
26.83%
15.10.21
15.10.21
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Esker S.A.
Start price
Target price
Perf. (%)
€285.00
17.09.21
17.09.21
€285.00
17.09.22
17.09.22
20.00%
15.11.21
15.11.21
Could be worthwhile Investment >10% per year
micromobility.com Inc.
Start price
Target price
Perf. (%)
€1,029.5
17.09.21
17.09.21
-
17.09.22
17.09.22
-28.03%
17.09.21
17.09.21
Risky Investment
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€3.00
17.09.21
17.09.21
-
17.09.22
17.09.22
73.33%
19.09.21
19.09.21
Risky Investment
Nano One Materials Corp
Start price
Target price
Perf. (%)
€2.77
16.09.21
16.09.21
-
16.09.22
16.09.22
-40.33%
16.03.22
16.03.22
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Below average Marketposition
Higher risks for its business
Sergeferrari Group S.A.
Start price
Target price
Perf. (%)
€9.39
16.09.21
16.09.21
€10.00
16.09.22
16.09.22
94.25%
22.03.22
22.03.22
Could be worthwhile Investment >10% per year
Seche Environnement
Start price
Target price
Perf. (%)
€57.00
15.09.21
15.09.21
€58.00
15.09.22
15.09.22
39.12%
16.09.22
16.09.22
Could be worthwhile Investment >10% per year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€2.94
15.09.21
15.09.21
-
15.09.22
15.09.22
0.00%
19.09.21
19.09.21
Risky Investment
AMC Entertainment Holdings Inc.
Start price
Target price
Perf. (%)
€39.00
15.09.21
15.09.21
-
25.08.22
25.08.22
-33.54%
29.03.22
29.03.22
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Probably not worthwhile Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€4.48
14.09.21
14.09.21
-
14.09.22
14.09.22
-4.46%
19.09.21
19.09.21
Risky Investment